Compare SLNG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNG | SEER |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.2M | 97.3M |
| IPO Year | 2019 | 2020 |
| Metric | SLNG | SEER |
|---|---|---|
| Price | $6.49 | $2.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 49.1K | ★ 889.1K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2400.00 | 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $68,245,000.00 | $16,578,000.00 |
| Revenue This Year | $8.66 | $2.14 |
| Revenue Next Year | $14.31 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $3.21 | $1.55 |
| 52 Week High | $6.36 | $2.41 |
| Indicator | SLNG | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 80.80 | 52.14 |
| Support Level | $3.45 | $1.85 |
| Resistance Level | N/A | $2.29 |
| Average True Range (ATR) | 0.40 | 0.09 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 79.16 | 63.51 |
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.